STAT· @statnews · X·· 7 天前精选AI 评分78
AI 导读
FDA 批准拜耳一款用于降低卒中复发风险的药物,该药属于一类有望更安全预防血栓的新型药物。STAT News 报道称,这是该类新药中首个获批上市的产品。
推荐理由
FDA 批准拜耳一款降低卒中复发风险的药物,属于一类有望更安全防血栓的新药。
正文
The FDA approved Bayer’s drug to reduce recurrence of stroke, making available the first in a novel class of medications that hold the promise of preventing blood clots more safely. https://www.statnews.com/2026/11/09/cardiovascular-stroke-recurrence-bayer-drug-fda-approval/
来源:STAT · x.com